Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors.
Inamoto T, Yamada T, Ohnuma K, Kina S, Takahashi N, Yamochi T, Inamoto S, Katsuoka Y, Hosono O, Tanaka H, Dang NH, Morimoto C.
Inamoto T, et al. Among authors: yamada t.
Clin Cancer Res. 2007 Jul 15;13(14):4191-200. doi: 10.1158/1078-0432.CCR-07-0110.
Clin Cancer Res. 2007.
PMID: 17634548